Prakt. lékáren. 2019; 15(2): 111-116 | DOI: 10.36290/lek.2019.021

Topical corticosteroids in extemporaneous prescription, part 1

Jan Hašek
Lékárna Slovanka, Česká Lípa

Glucocorticoids are the strongest known anti-inflammatory agents. They are used broadly in various medical disciplines. The present article is aimed at the dermatological formulation. It deals with the aspects affecting absorption of topical corticosteroids from the vehicles as well as with the classification of individual agents based on effect strength, and provides notes on the therapeutic index of selected compounds. In terms of magistral preparation, galenic properties of topical corticosteroids are presented, as are the possibilities of formulating substances into a compounded drug in general terms. Also presented are the factors affecting stability. The text contains examples of particular formulations used in the practice.

Keywords: topical corticosteroids, extemporaneous preparation, dermatological formulation

Published: June 20, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hašek J. Topical corticosteroids in extemporaneous prescription, part 1. Praktické lékárenství. 2019;15(2):111-116. doi: 10.36290/lek.2019.021.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Högger P. Glucocorticoidhaltige Magistralrezepturen. Pharm Unserer Zeit, 2010; 39(4): 294-299 Go to original source... Go to PubMed...
    2. Bandyopadhyay D. A treatise on topical corticosteroids in dermatology. Use, misuse and abuse. Singapore: Springer Nature, 2018: 333 Go to original source...
    3. Viktorinová M. Přehled lokálních kortikosteroidů v dermatologii 1. Možnosti léčby kožních chorob kortikosteroidními externy. Klin Farmakol Farm 2006, 20(4): 202-210
    4. Garbe C, Reimann H. Dermatologische Rezepturen. 2 vyd. Stuttgard: Gregor Thieme Verlag, 2005: 320 Go to original source...
    5. Luger T. Loske KD. Elsner P et al. Topische Dermatotherapie mit Glukokortikoiden - Therapeutischer Index. J Dtsch Dermatol Ges, 2014; (2): 629-634 Go to original source...
    6. Willner B, Cutt I. Galenische Übungen. 18. vyd. Eschborn: Govi-Verlag Pharmazeutischer Verlag Gmbh, 2011: 482
    7. DAC/NRF-Rezepturhinweis Glucocorticoide. Dosupné z https://dacnrf.pharmazeutische-zeitung.de/index.php?id=rh-ausgabe & nrf_id=785 (datum náhledu 1. 11. 2018)
    8. Deutschen Arzneimittel-Codex (DAC)/Neues Rezeptur-Formularium (NRF). vydání 2015, Stuttgart: Govi-Verlag Eschborn, 2015.
    9. Sklenář Z. Horáčková K. Nové léčivé látky v magistraliter receptuře IX - fluocinolon-acetonid. Prakt. Lékáren. 2011; 7(3): 121-125
    10. Sklenář Z. Magistraliter receptura v dermatologii. 1. vyd. Praha: Galén, 2009: 441
    11. DAC/NRF-Rezepturhinweis Zinkoxid. dostupné z https://dacnrf.pharmazeutische-zeitung.de/index.php?id=rh-ausgabe & nrf_id=979 Datum náhledu 1. 11. 2018
    12. Tabellen für die Rezeptur Plausibilitätsprüfung in der Apotheke. 10. vydání. Eschborn: Avoxa - Mediengruppe Deutscher Apotheker GmbH, 2018: 94
    13. Fritsch P. Schwarz T. Dermatologie Venerologie Grundlagen. Klinik. Atlas. 3. vydání. Berlin: Springer-Verlag Gmbh Deutschland, 2018: 1216 Go to original source...
    14. Pokyn SÚKL LEK-5 verze 8. Dostupné z http://www.sukl.cz/lekarny/lek-5-verze-8 (datum náhledu 30. 11. 2018)
    15. DAC/NRF-Rezepturfinder. dostupné z https://dacnrf.pharmazeutische-zeitung.de/index.php?id=rezepturenfinderdetail & uid=2855 Datum náhledu 27. 1. 2019
    16. Sklenář Z. Horáčková K. Nové léčivé látky v magistraliter receptuře VIII - betamethason-dipropionát. Prakt. lékáren. 2011; 7(2): 76-79

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.